MagForce AG (MGFRF) Stock
MagForce AG focuses on innovative nanotechnology-driven cancer therapy, with operations spanning Germany and Poland. The company's key offerings include NanoTherm, a therapeutic solution for brain tumors; NanoPlan, specialized software designed to assist medical professionals in crafting optimal treatment strategies for NanoTherm; and the NanoActivator, a device engineered to generate magnetic fields.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cash Flow (USD)
Valuation & Return Ratios
Peer Comparison
About MagForce AG
MagForce AG focuses on innovative nanotechnology-driven cancer therapy, with operations spanning Germany and Poland. The company's key offerings include NanoTherm, a therapeutic solution for brain tumors; NanoPlan, specialized software designed to assist medical professionals in crafting optimal treatment strategies for NanoTherm; and the NanoActivator, a device engineered to generate magnetic fields. Established in 1997, MagForce AG maintains its primary office in Berlin, Germany.
MagForce AG (MGFRF) stock trades at $0.00 with a market capitalization of $11973. The stock is valued at a price-to-earnings (P/E) ratio of -291.25, price-to-book of 0.00, price-to-sales of 9.91.
On profitability, MagForce AG generates a return on equity (ROE) of -40.74%, return on capital employed of -12.02%.
Official website: www.magforce.com